AUS
NZ
UK
CA
USA
IND
On July 24, 2026, L1 Capital Pty Ltd, a director at Anteris Technologies Global Corp. (NASDAQ:AVR), sold 23,000 shares of the company's common stock at $8.13 per share. This insider transaction, reported to the Securities and Exchange Commission on July 28, 2026, highlights notable insider activity within the NASDAQ-listed medical technology firm. Despite the sale, L1 Capital continues to hold an indirect beneficial interest in approximately 7.789 million shares across various controlled funds, maintaining a significant ownership stake in Anteris Technologies.
Key Highlights
- Stock symbol: NASDAQ: AVR
- L1 Capital Pty Ltd sold 23,000 Anteris Technologies common shares on July 24, 2026, at $8.13 each
- Post-sale, L1 Capital retains indirect beneficial ownership of 7,789,000 common shares plus 5,359,470 CHESS Depository Interests
- Melbourne-based L1 Capital acts as a company director and manages multiple long-short investment funds holding these shares
Details of the Insider Share Sale and Pricing
L1 Capital Pty Ltd executed a sale of 23,000 common shares of Anteris Technologies on July 24, 2026, at a price of $8.13 per share. This transaction, classified as a sale under securities trading codes, provides insight into the valuation of AVR stock at the time of the insider activity. Investors tracking historical insider transactions can use this pricing data to analyze market sentiment and company valuation trends.
The sale likely reflects L1 Capital's strategic portfolio management decisions and market outlook. While the transaction reduced the direct common stock holdings of L1 Capital, the firm’s overall beneficial ownership remains substantial. Insider transaction pricing and volume often serve as indicators of insider confidence and company prospects.
L1 Capital's Significant Ownership Following the Transaction
After the July 24, 2026 sale, L1 Capital Pty Ltd continues to hold indirect beneficial ownership of 7,789,000 Anteris Technologies common shares. This sizeable stake is held through multiple investment funds under L1 Capital’s control, rather than direct ownership by the entity itself, reflecting a common institutional investment structure.
Additionally, L1 Capital disclosed ownership of 5,359,470 CHESS Depository Interests (CDIs) following a transaction on July 27, 2026. Each CDI corresponds to one underlying share of Anteris Technologies common stock and is exchangeable within 60 days. This dual holding structure offers L1 Capital flexibility in managing its stake while maintaining significant influence as both a major shareholder and company director.
Investment Fund Structure Behind L1 Capital’s Holdings
The beneficial ownership is spread across seven investment funds managed by L1 Capital Pty Ltd, including the L1 Long Short Fund Limited, L1 Capital Long Short Fund, L1 Capital Long Short (Master) Fund, L1 Capital Global Long Short (Master) Fund, L1 Capital Global Long Short Fund, L1 Capital Global Long Short (AUD Offshore) Fund, and L1 Global Long Short Fund Limited. This diversified multi-fund approach reflects a sophisticated investment strategy targeting various investor segments and regions.
These long-short funds employ both long and short positions across different securities and markets. Allocating Anteris Technologies shares across these funds enables strategic portfolio management aligned with each fund’s mandate. As a Melbourne-based manager holding a major position in a US NASDAQ-listed company, L1 Capital exemplifies the role of international institutional investors in American capital markets. Its director role at Anteris Technologies further emphasizes the strategic nature of this investment.
CHESS Depository Interests and Their Exchangeability
L1 Capital’s 5,359,470 CHESS Depository Interests, acquired on July 27, 2026, represent a significant portion of its holdings. Each CDI can be converted into one Anteris Technologies common share within a 60-day period, providing operational flexibility to convert holdings as needed for investment or administrative purposes.
CDIs facilitate cross-border securities trading and settlement. Holding both direct shares and CDIs suggests L1 Capital acquired its stake through multiple channels or at different times. The 60-day conversion window allows L1 Capital to adjust its ownership structure and voting power strategically.
Governance Role and Insider Transaction Implications
L1 Capital Pty Ltd holds a director position on Anteris Technologies’ board, extending its role beyond that of a passive investor. This governance role entails additional disclosure and oversight responsibilities under securities laws, particularly regarding insider transactions. The timing and scale of the recent insider sales may provide insights into management’s confidence in the company’s valuation and strategic direction.
Insiders and directors face close scrutiny when conducting securities transactions. Notably, L1 Capital claims exemption from filing ownership reports under the Securities Exchange Act of 1934 pursuant to Rule 16a-2, though it voluntarily filed the Form 4 disclosure to maintain transparency about its beneficial ownership changes.
Regulatory Compliance and Exemption Claims
The filing includes a statement that L1 Capital Pty Ltd does not admit an obligation to file ownership reports under the Securities Exchange Act of 1934, citing exemption under Rule 16a-2. This indicates some ambiguity regarding its regulatory filing requirements. Nevertheless, L1 Capital’s decision to file the Form 4 demonstrates a commitment to transparency and investor protection.
Rule 16a-2 exempts certain reporting persons from filing obligations depending on their status. Filing disclosures despite claiming exemption is a cautious compliance approach that helps avoid regulatory conflicts while ensuring market transparency about significant insider transactions.
Transaction Timing and Market Valuation Context
The insider transactions occurred on consecutive business days: the common stock sale on July 24, 2026, and the CHESS Depository Interest sale on July 27, 2026. This timing suggests a coordinated portfolio rebalancing or asset allocation adjustment by L1 Capital across its funds.
The sale prices—$8.13 per share for common stock and $8.15 per CDI—reflect consistent valuations with a slight premium for the CDIs, likely due to liquidity or market factors. Investors often analyze insider transaction pricing to gauge insider sentiment and company valuation.
SEC Filing Timeline and Disclosure Details
The insider transaction disclosures were filed with the SEC on July 28, 2026, four days after the initial sale. Joel Arber, a director, authorized the filing on behalf of L1 Capital Pty Ltd, confirming adherence to regulatory filing standards.
The Form 4 separates the common stock transaction (Table I) and the CHESS Depository Interest transaction (Table II), allowing clear distinction between security types. The filing provides detailed information on conversion rights, beneficial ownership, and transaction nature, enhancing transparency for regulators and investors.
International Institutional Investor Influence in US Markets
L1 Capital Pty Ltd’s role as a director and major shareholder of a NASDAQ-listed firm underscores the significant involvement of international investors in US capital markets. Based in Melbourne, Australia, L1 Capital manages diversified portfolios that include substantial US medical technology holdings, highlighting the global nature of investment management.
This international ownership brings diverse perspectives on corporate governance and strategy. L1 Capital’s board representation at Anteris Technologies reflects its status as a long-term, strategic investor rather than a short-term market participant, indicating a strong commitment to the company’s future.
